KARTHIK GIRIDHAR, MD
Medical Oncology Physician · ROCHESTER, MN
Individual Active NPI 1962778183
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 470 | 86,736 | $7,109,680 | $2,323,651 | $1,849,384 |
| 2023 | 385 | 60,732 | $5,358,875 | $1,743,776 | $1,387,966 |
| 2022 | 299 | 35,334 | $2,807,407 | $959,645 | $764,243 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 10,804 | $45 | $36 |
| J1453 | Injection, fosaprepitant, 1 mg | 10,200 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 8,149 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 6,481 | $50 | $39 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 4,340 | $0 | $0 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,507 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1,300 | $1 | $1 |
| J9041 | Injection, bortezomib, 0.1 mg | 1,295 | $2 | $1 |
| Q5115 | Injection, rituximab-abbs, biosimilar, (truxima), 10 mg | 1,020 | $33 | $26 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 720 | $0 | $0 |
| 96375 | Injection of additional new drug or substance into vein | 459 | $16 | $13 |
| J9045 | Injection, carboplatin, 50 mg | 356 | $4 | $3 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | 59131 | MN |
| Hematology & Oncology Physician | 207RH0003X | 59131 | MN |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Minnesota
- NPI 1437278959
- NPI 1003376468
- NPI 1982680583
- NPI 1801877501
- NPI 1437136553
- NPI 1417148180
- NPI 1306879028
- NPI 1265729834
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.